{"log_id": 395282320988320814, "direction": 0, "words_result_num": 31, "words_result": [{"probability": {"variance": 0.017042, "average": 0.942806, "min": 0.51939}, "location": {"width": 904, "top": 200, "height": 45, "left": 200}, "words": " hmg-coa还原酶抑制剂:增加肌肉不良反应如横纹肌溶解症的发生率"}, {"probability": {"variance": 0.003186, "average": 0.965832, "min": 0.837509}, "location": {"width": 207, "top": 266, "height": 36, "left": 202}, "words": "谨慎合用的药物"}, {"probability": {"variance": 0.003912, "average": 0.974281, "min": 0.732229}, "location": {"width": 1125, "top": 330, "height": 47, "left": 202}, "words": "口服抗凝剂:与口服抗凝剂合月后,增加出血的危险性(由于它们与血浆蛋白发生了置换"}, {"probability": {"variance": 0.016877, "average": 0.936009, "min": 0.4901}, "location": {"width": 1123, "top": 394, "height": 47, "left": 202}, "words": "反应).对INR进行更频繁的检查和监控,在用非诺贝特治疗期间和停药B元后,节口"}, {"probability": {"variance": 0.016981, "average": 0.931727, "min": 0.619229}, "location": {"width": 207, "top": 462, "height": 31, "left": 200}, "words": "胫抗凝剂的剂量"}, {"probability": {"variance": 1.7e-05, "average": 0.995886, "min": 0.989283}, "location": {"width": 159, "top": 524, "height": 36, "left": 209}, "words": "【药物过量】"}, {"probability": {"variance": 8.3e-05, "average": 0.988923, "min": 0.977499}, "location": {"width": 120, "top": 592, "height": 34, "left": 255}, "words": "对症治疗"}, {"probability": {"variance": 7e-06, "average": 0.997869, "min": 0.992003}, "location": {"width": 161, "top": 656, "height": 34, "left": 207}, "words": "【药理毒理】"}, {"probability": {"variance": 0, "average": 0.998898, "min": 0.997917}, "location": {"width": 120, "top": 720, "height": 34, "left": 198}, "words": "药理作用"}, {"probability": {"variance": 0.002963, "average": 0.975943, "min": 0.719578}, "location": {"width": 1068, "top": 786, "height": 50, "left": 257}, "words": "本品为一种新型制剂,含有200mg高生物利用度非诺贝特。非诺贝特可降低血清胆固"}, {"probability": {"variance": 0.000539, "average": 0.98579, "min": 0.907725}, "location": {"width": 483, "top": 852, "height": 36, "left": 195}, "words": "醇20~25%,降低甘油三酯40~50%"}, {"probability": {"variance": 0.002763, "average": 0.975447, "min": 0.745435}, "location": {"width": 1066, "top": 916, "height": 47, "left": 255}, "words": "胆固醇的降低是通过降低低度动粥样化成分(VDL和LDL),并且通过降低总"}, {"probability": {"variance": 0.016137, "average": 0.939081, "min": 0.432106}, "location": {"width": 1066, "top": 982, "height": 47, "left": 252}, "words": "胆HDL胆固醇比率取得的(该比率在动脉粥样化高脂血症中升高),从而改善了"}, {"probability": {"variance": 0.062587, "average": 0.853169, "min": 0.374373}, "location": {"width": 262, "top": 1050, "height": 31, "left": 255}, "words": "血浆中固的分布"}, {"probability": {"variance": 0.010172, "average": 0.967335, "min": 0.533785}, "location": {"width": 1125, "top": 1112, "height": 50, "left": 195}, "words": "高胆固醇和动脉粥样硬化的关系,以及动脉硬化与冠状动脉疾病危险的夫系已得到证"}, {"probability": {"variance": 0.02855, "average": 0.913853, "min": 0.396743}, "location": {"width": 1050, "top": 1180, "height": 43, "left": 255}, "words": "实低水平的HDL可增加冠状动脉疾病危险。甘油三酯升高可增加心上管病危险"}, {"probability": {"variance": 6.4e-05, "average": 0.995525, "min": 0.970745}, "location": {"width": 464, "top": 1244, "height": 38, "left": 255}, "words": "但还不能确定这种关系是独立存在的"}, {"probability": {"variance": 0.005438, "average": 0.963364, "min": 0.646161}, "location": {"width": 843, "top": 1310, "height": 45, "left": 255}, "words": "另外,甘注三酯可能不仅与动脉粥样化有关,而且与血检形成有关"}, {"probability": {"variance": 0.004619, "average": 0.966451, "min": 0.710542}, "location": {"width": 1064, "top": 1374, "height": 50, "left": 255}, "words": "通过有效延长治疗期(显著降低胆醇),血管外胆固醇的沉积(腱科结节黄瘤)能"}, {"probability": {"variance": 0.001008, "average": 0.978636, "min": 0.897987}, "location": {"width": 419, "top": 1442, "height": 36, "left": 255}, "words": "够有明显的退,甚至完全消除"}, {"probability": {"variance": 0.007207, "average": 0.914229, "min": 0.829336}, "location": {"width": 152, "top": 1460, "height": 59, "left": 989}, "words": "业有"}, {"probability": {"variance": 0.008946, "average": 0.962261, "min": 0.619563}, "location": {"width": 961, "top": 1506, "height": 45, "left": 252}, "words": "在高脂血症病人中非诺贝特有利尿酸的作用,可使血浆中尿酸平均降低25%"}, {"probability": {"variance": 0.031444, "average": 0.865956, "min": 0.365794}, "location": {"width": 1064, "top": 1570, "height": 47, "left": 252}, "words": "非诺贝治疗增加apol、降低apB,从改 apoa't'aocb比率该比值被认为是"}, {"probability": {"variance": 0.001045, "average": 0.983948, "min": 0.89896}, "location": {"width": 234, "top": 1638, "height": 34, "left": 252}, "words": "动脉粥样化的标志"}, {"probability": {"variance": 0.01418, "average": 0.951041, "min": 0.545529}, "location": {"width": 1068, "top": 1704, "height": 41, "left": 250}, "words": "动物研究和人体临床研究表明,非诺贝特具有抗血小板凝集的作用,该作用是通过降"}, {"probability": {"variance": 0.001623, "average": 0.978038, "min": 0.843786}, "location": {"width": 742, "top": 1768, "height": 38, "left": 250}, "words": "低ADP、花生四烯酸和肾上腺素所致的凝集反应而实现的"}, {"probability": {"variance": 0.018786, "average": 0.928433, "min": 0.481377}, "location": {"width": 1066, "top": 1832, "height": 50, "left": 250}, "words": "非诺贝特通过活 PPAR a(过氧化物酶增殖体激活受体a)激活脂释酶和减少载"}, {"probability": {"variance": 0.015643, "average": 0.92672, "min": 0.471198}, "location": {"width": 861, "top": 1900, "height": 41, "left": 250}, "words": "脂蛋白CⅢI合成,使血浆中脂肪降解和十油三酯清除明显增如"}, {"probability": {"variance": 3.5e-05, "average": 0.994413, "min": 0.985484}, "location": {"width": 132, "top": 1964, "height": 36, "left": 193}, "words": "毒理研究:"}, {"probability": {"variance": 0.014427, "average": 0.940125, "min": 0.376566}, "location": {"width": 1080, "top": 2030, "height": 43, "left": 250}, "words": "在使用剂量超过45mg/kg时发现了小鼠大鼠肝脏的肿瘤和/或肝细胞癌在此剂"}, {"probability": {"variance": 0.021568, "average": 0.914856, "min": 0.449888}, "location": {"width": 1109, "top": 2094, "height": 50, "left": 191}, "words": "同样发现大鼠胰腺腺泡纽胞瘤和腺癌,在长期应月60mg/ks的大鼠丸发现了间质细胞瘤"}], "language": 3}